Robert Seder
9Patents
2h-index
17Co-inventors
40Inventor score
Filing activity: Sep 9, 2016 → Nov 2, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10799580B2 | Expression vector delivery system and use thereof for inducing an immune response | Human Necessities | 4 | Active |
| US11191821B2 | Peptide vaccine formulations and use thereof for inducing an immune response | Performing Operations; Transporting | 2 | Active |
| US11938177B2 | Peptide vaccine formulations and use thereof for inducing an immune response | Performing Operations; Transporting | 1 | Active |
| US10197577B2 | Serum antibody assay for determining protection from malaria, and pre-erythrocytic subunit vaccines | Emerging Cross-Sectional Technologies | 0 | Active |
| US11760794B2 | Neutralizing antibodies to plasmodium falciparum circumsporozoite protein and their use | Emerging Cross-Sectional Technologies | 0 | Active |
| US12269872B2 | Neutralizing antibodies to Plasmodium falciparum circumsporozoite protein and their use | Emerging Cross-Sectional Technologies | 0 | Active |
| US12383618B2 | Expression vector delivery system and use thereof for inducing an immune response | Human Necessities | 0 | Active |
| US11865168B2 | Compositions and methods for treating bacterial infections | Human Necessities | 0 | Active |
| US11021535B2 | Neutralizing antibodies to plasmodium falciparum circumsporozoite protein and their use | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.